DiGeorge Syndrome (DGS) is a primary immunodeficiency disease associated with susceptibility to infections due to poor T cell production and function.
While DGS is a lifelong condition, it mostly affects infants and children. Depending on the severity of the syndrome, recurrent infections tend to decrease in late childhood and adulthood. Still, approximately one-third of affected adults will have mild recurrent infections. Children with DGS differ in the organs and tissues affected, as well as in the severity of the disease.
DiGeorge Syndrome (DGS) is a primary immunodeficiency disease associated with susceptibility to infections due to poor T cell production and function.
While DGS is a lifelong condition, it mostly affects infants and children. Depending on the severity of the syndrome, recurrent infections tend to decrease in late childhood and adulthood. Still, approximately one-third of affected adults will have mild recurrent infections. Children with DGS differ in the organs and tissues affected, as well as in the severity of the disease.
Introduction, causes and symptoms, Mechanism and treatment are been explained about this deadly disease SCID where production of T and B cells is affected.
dendritic cells are part of innate immune system, antigen presenting cells in skin, activation of t cells and inducing and maintaining immune tolerance, 4 types- langerhans cells, dermal dendritic cells, merkel cells, melanocytes
Secondary Immunodeficiency
By Dr. Usama Ragab Youssif
Reference: Included in Slides
Include causes of secondary immunodeficiency including AIDS and other viral infections
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
Patient was diagnosed with x-linked agammaglobulinemia leading to re.pdfmichaelazach6427
Patient was diagnosed with x-linked agammaglobulinemia leading to recurrent bacterial
infections. Patient was determined by DNA sequencing to have a nonsense mutation in the btk
gene on his X chromosome resulting in premature truncation of the Bruton’s tyrosine kinase
(BTK) protein. This mutation has been previously reported in patients with susceptibility to
bacterial infections resulting in recurrent infection. Mother is heterozygous for the mutation and
received genetic counseling in case they decide to have additional offspring as ~50% of male
children will have similar disease, and 50% of daughters will be asymptomatic carriers. How
would you treat this patient? What are some possible side effects associated with this treatment?
Do the pros outweigh the cons? Please be specific.
Solution
There is 30-50% chance of XLA patients having a positive family history of genetic inheritance.
The rest of the cases occur as random mutations. XLA diagnosis usually begins due to a history
of recurrent infections, mostly in the respiratory tract, through childhood. This is due to humoral
immunodeficiency. The most common treatment for XLA is an intravenous infusion of
immunoglobulin (IVIg, human IgG antibodies) every 3–4 weeks, for life. IVIg is a human
product extracted and pooled from thousands of blood donations. IVIg does not cure XLA but
increases the patient\'s lifespan and quality of life, by generating passive immunity, and boosting
the immune system. With treatment, the number and severity of infections is reduced. With IVIg,
XLA patients may live a relatively healthy life. A patient should attempt reaching a state where
his IgG blood count exceeds 800 mg/kg. The dose is based on the patient\'s weight and IgG
blood-count. Antibiotics are another common supplementary treatment. Local antibiotic
treatment are preferred over systemic treatment (pills) for long-term treatment, if possible.One of
the future prospects of XLA treatment is gene therapy, which could potentially cure XLA. Gene
therapy technology is still in its infancy and may cause severe complications such as cancer and
even death. XLA patients are specifically susceptible to viruses of the Enterovirus family, and
mostly to: polio virus, coxsackie virus and Echoviruses. These may cause severe central nervous
system conditions as chronic encephalitis, meningitis and death. An experimental anti-viral
agent, pleconaril, is active against picornaviruses. XLA patients, however, are apparently
immune to the Epstein-Barr virus (EBV), as they lack mature B cells needed for the viral
infection. Patients with XLA are also more likely to have a history of septic arthritis.
Agammaglobulinemia (XLA) is similar to the primary immunodeficiency and their clinical
conditions and treatment are almost identical..
Introduction, causes and symptoms, Mechanism and treatment are been explained about this deadly disease SCID where production of T and B cells is affected.
dendritic cells are part of innate immune system, antigen presenting cells in skin, activation of t cells and inducing and maintaining immune tolerance, 4 types- langerhans cells, dermal dendritic cells, merkel cells, melanocytes
Secondary Immunodeficiency
By Dr. Usama Ragab Youssif
Reference: Included in Slides
Include causes of secondary immunodeficiency including AIDS and other viral infections
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
Patient was diagnosed with x-linked agammaglobulinemia leading to re.pdfmichaelazach6427
Patient was diagnosed with x-linked agammaglobulinemia leading to recurrent bacterial
infections. Patient was determined by DNA sequencing to have a nonsense mutation in the btk
gene on his X chromosome resulting in premature truncation of the Bruton’s tyrosine kinase
(BTK) protein. This mutation has been previously reported in patients with susceptibility to
bacterial infections resulting in recurrent infection. Mother is heterozygous for the mutation and
received genetic counseling in case they decide to have additional offspring as ~50% of male
children will have similar disease, and 50% of daughters will be asymptomatic carriers. How
would you treat this patient? What are some possible side effects associated with this treatment?
Do the pros outweigh the cons? Please be specific.
Solution
There is 30-50% chance of XLA patients having a positive family history of genetic inheritance.
The rest of the cases occur as random mutations. XLA diagnosis usually begins due to a history
of recurrent infections, mostly in the respiratory tract, through childhood. This is due to humoral
immunodeficiency. The most common treatment for XLA is an intravenous infusion of
immunoglobulin (IVIg, human IgG antibodies) every 3–4 weeks, for life. IVIg is a human
product extracted and pooled from thousands of blood donations. IVIg does not cure XLA but
increases the patient\'s lifespan and quality of life, by generating passive immunity, and boosting
the immune system. With treatment, the number and severity of infections is reduced. With IVIg,
XLA patients may live a relatively healthy life. A patient should attempt reaching a state where
his IgG blood count exceeds 800 mg/kg. The dose is based on the patient\'s weight and IgG
blood-count. Antibiotics are another common supplementary treatment. Local antibiotic
treatment are preferred over systemic treatment (pills) for long-term treatment, if possible.One of
the future prospects of XLA treatment is gene therapy, which could potentially cure XLA. Gene
therapy technology is still in its infancy and may cause severe complications such as cancer and
even death. XLA patients are specifically susceptible to viruses of the Enterovirus family, and
mostly to: polio virus, coxsackie virus and Echoviruses. These may cause severe central nervous
system conditions as chronic encephalitis, meningitis and death. An experimental anti-viral
agent, pleconaril, is active against picornaviruses. XLA patients, however, are apparently
immune to the Epstein-Barr virus (EBV), as they lack mature B cells needed for the viral
infection. Patients with XLA are also more likely to have a history of septic arthritis.
Agammaglobulinemia (XLA) is similar to the primary immunodeficiency and their clinical
conditions and treatment are almost identical..
ABO Blood grouping in-compatibility in pregnancyMs. Sapna Pal
Rhesus (Rh) incompatibility is a crucial topic in the realm of pregnancy and childbirth. This condition arises when a pregnant woman, who is Rh-negative, carries a fetus with Rh-positive blood, causing a potential mismatch that can lead to serious complications. Understanding the mechanisms and implications of Rh incompatibility is paramount for healthcare providers and expecting parents alike. Let's delve into this intricate interplay between blood types, antibodies, and pregnancy, to grasp the significance of Rh incompatibility and its management.
Jual obat aborsi asli solo WA-081222292216 bergaransi tuntas bersihKlinik Cytotec
⭐⭐⭐PESAN PRODUK ASLI ⭐⭐⭐
0812 - 2229 - 2216
JUAL OBAT ABORSI CYTOTEC 0812 2229 2216 OBAT ABORSI 1 2 3 4 5 6 BULAN 100% AMPUH | OBAT CYTOTEC MISOPROSTOL | OBAT PENGGUGUR KANDUNGAN | OBAT PENDORONG JANIN | OBAT PELANCAR HAID | OBAT TELAT BULAN ASLI | OBAT ABORSI ALAMI CARA PALING AMAN UNTUK MENUNDA ATAU MENGGUGURKAN KEHAMILAN.
Jual Obat Aborsi WA 081222292216 Obat Penggugur Kandungan Asli Obat Aborsi Cytotec & Gastrul Asli 100% Manjur Dan Aman. Obat Penggugur Kandungan, Obat Aborsi, Harga Obat Aborsi, WA 081222292216 | Jual Obat Aborsi Usia 1 Bulan, Jual Obat Aborsi Usia 2 Bulan, Jual Obat Aborsi Usia 3 Bulan, Jual Obat Aborsi Usia 4 Bulan, Jual Obat Aborsi Usia 5 Bulan, Jual Obat Aborsi Usia 6 Bulan, Cytotec Asli, Pil Cytotec, Pil Aborsi Ampuh, Obat Menggugurkan Kandungan, Obat Menghilangkan Janin, Obat Gastrul Asli, Obat Penggugur Kandungan Asli, Obat Penggugur Kandungan Usia 1-7 Bulan, Obat Telat Bulan, Obat Telat Haid, Obat Aborsi Ampuh, Obat Aborsi Cytotec, Obat Aborsi Asli, Obat Cytotec Asli. Obat Aborsi dengan obat-obatan Menggugurkan kandungan yang bisa dilakukan dengan menggunakan pil aborsi. Jika obat-obatan yang digunakan memang terjamin keasliannya dan Anda mendapatkan dari sumber terpercaya, pengobatan aborsi merupakan pilihan aman bagi kehamilan sampai 20 minggu. Ada dua cara menghentikan kehamilan dengan obat-obatan.Misoprostol atau Cytotec sajaPerempuan juga bisa menggunakan hanya Misoprostol untuk menggugurkan kandungan. Tentu saja dosnya berbeda jika dibandingkan dengan kombinasi Mifepristone dan Misoprostol. Tingkat keberhasilannya bisa mencapai 99%. Lalu, apa itu cytotec? Cytotec adalah nama merek dagang dari Misoprostol. Nama lain yang mungkin sering disebut di Indonesia adalah gastrul, misotab, dan chromelux. Pahami Bahaya Penggunaan Obat Aborsi Tanpa Pengawasan Dokter Saat ini banyak produk obat aborsi yang dijual “gelap” atau tanpa resep dokter. Perlu diketahui, obat tersebut bukan obat yang diracik khusus untuk menggugurkan kandungan. Misoprostol misalnya, sebenarnya diproduksi untuk mengobati penyakit lambung. Namun, obat tersebut diketahui memicu kontraksi dan meluruhkan dinding rahim. Kondisi ini bisa berefek pada gugurnya janin jika dikonsumsi oleh ibu hamil. Aborsi yang dilakukan dengan obat misoprostol biasanya digunakan saat usia kehamilan di bawah 25 minggu atau 6 bulan. Pada beberapa kasus, misoprostol digunakan secara bersamaan dengan obat lain, seperti mifepristone. Namun, mifepristone cenderung sulit didapat dan harganya jauh lebih mahal daripada misoprostol, sehingga banyak orang yang menggunakan misoprostol saja. Lalu, apakah berbahaya mengonsumsi obat aborsi tanpa pengawasan dokter? Tentu saja sudah. Sebab, hanya dokter dan tenaga kesehatan yang dapat menentukan apakah obat-obatan tersebut aman dikonsumsi. Selain itu, saran yang dibutuhkan dari dokter terkait dengan apa yang harus digunakan, aturan penggunaan, dan obat-obatan lain yang harus digunakan untuk meringankan gejala yang muncul ak
Screening for any disorder in individuals is a strategy used for identifying a disease before the onset of signs or symptoms, thus enabling earlier detection and management with the aim to reduce morbidity and mortality.
Dr. Arun aggarwal Gastroenterologist :
Variable degree of villous atrophy without marked crypt hyperplasia, abnormal accumulation of PAS positive material in the apical cytoplasm of upper crypt and mature enterocytes and absent neutral PAS staining of the enterocyte brush border membrane
Similar to X linked agammaglobulinemia #Bruton Agammaglobulinemia #Ayurveda in Agammaglobulinemia (20)
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
X linked agammaglobulinemia #Bruton Agammaglobulinemia #Ayurveda in Agammaglobulinemia
1. Short Note on Bruton
Agammaglobulinemia
Presented By : Dr. Vijay Kumar Pathak
2. • Bruton agammaglobulinemia is X-linked inherited immunodeficiency
disease.
• It is caused by mutations in the gene coding for Bruton tyrosine kinase
(BTK)
• The disease was first elucidated by Bruton in 1952, for whom the gene is
named.
• Also known as X-linked agammaglobulinemia (XLA).
mature B cells
Pre–B
cells
BTK
5. XLA is an inherited disease that occurs in approximately 1 in 250,000 males.
Female carriers have no clinical manifestations.
Infections begin once transferred maternal immunoglobulin G (IgG) antibodies have
been catabolized, typically at about 6 months of age.
Baby has small or absent tonsils and lymph nodes with recurrent or severe bacterial
infections.
Children typically clinically manifest the disease at age 3-9 months with pneumonia,
otitis media, cellulitis, meningitis, osteomyelitis, diarrhea, or sepsis.
Rare cases of adults in their second decade have been diagnosed with a milder form
6. 1. Immunoglobulins (IgG, IgM and IgA) are markedly reduced or absent.
2. Abnormally low or absent numbers of mature B lymphocytes,
3. Absence of BTK ribonucleic acid (RNA) or protein.
4. Rarely, the diagnosis is made in adults in their second decade of life. This is
thought to be due to a mutation in the protein, rather than a complete absence.
7. Medical Care
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton
agammaglobulinemia.
Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg given every 3-4 weeks.
Doses and intervals can be adjusted based on individual clinical responses.
Therapy should begin at age 10-12 weeks.
Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for
common sinopulmonary infections.
Nutritional supplementation with multivitamins is recommended.
8. AYURVEDA VIEW
Inappropriate Ritu (Fertile period), Kshetra (Uterus), Ambu (Ahara rasa nutrients) and Bija (sperm
and ovum), Dauhrida Avamanana (negligence of urges during Dauhrida stage of pregnant
women), Garbhopaghatkarbhava (Dont’s in Antenatal period), incompatible Garbha
Vriddhikarabhava (embryonic growth factors) and improper following of Garbhini Paricharya
Beejdushti (Abnormality in Gene / Mutation)
Khavagunya (Organs predisposed to disease)
Dosha Sthan sanshraya (Poorly developed Lymphoid organ)
Vyadhi (Bruton agammaglobulinemia)
9. AYURVEDIC MANAGEMENT
Line of treatment might be
• Oja vardhan
• Agni deepan
• Ayurvedic immune inhancing drugs example swarnaprashan
• Vaat anuloman
• Based upon clinical sign and symptoms management is done